The University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
Health Expect. 2021 May;24 Suppl 1(Suppl 1):82-94. doi: 10.1111/hex.13031. Epub 2020 Feb 7.
Adherence to ADHD medication is a complex phenomenon as the decision to adhere is influenced by a range of factors. To design tailored interventions to promote adherence, it is important to understand the factors that influence adherence in the context of its three phases: initiation, implementation and discontinuation.
The objective of this study was to explore the phase-specific factors that influence adherence to medication in adults who have a diagnosis of ADHD.
Three focus groups (FGs) were conducted with twenty adults with ADHD in different metropolitan areas of Sydney, Australia. FGs were transcribed verbatim and thematically analysed.
Participants' decision to initiate medication (the initiation phase) was influenced by their perceived needs (desire to improve academic and social functioning) and concerns (fear of side-effects) about medication following a similar process as defined by the Necessity-Concerns Framework (NCF). The balance between benefits of medication (needs) and side-effects (concerns) continued to determine participants' daily medication-taking (the implementation phase) and persistence (or discontinuation) with their medication. Forgetfulness and stigma were reported as concerns negatively impacting the implementation phase, while medication cost and dependence influenced the discontinuation phase of adherence.
Adults' decision to initiate, continue or discontinue medication is influenced by a range of factors; some are unique to each phase while some are common across the phases. Participants balanced the needs for the medication against their concerns in determining whether to adhere to medication at each phase. It appears that the NCF has applicability when decision making about medication is explored at the three phases of adherence.
ADHD 药物治疗的依从性是一个复杂的现象,因为坚持治疗的决定受到一系列因素的影响。为了设计有针对性的干预措施来促进依从性,了解影响依从性的因素非常重要,这些因素涉及依从性的三个阶段:开始、实施和停止。
本研究的目的是探讨影响成年 ADHD 患者药物治疗依从性的特定于各阶段的因素。
在澳大利亚悉尼不同大都市区进行了三次焦点小组(FG)访谈,参与者为 20 名成年 ADHD 患者。FG 的转录内容进行了主题分析。
参与者决定开始用药(开始阶段)受到他们对药物的感知需求(改善学业和社交功能的愿望)和担忧(对副作用的恐惧)的影响,这个过程与必要性-担忧框架(NCF)所定义的过程相似。药物的益处(需求)和副作用(担忧)之间的平衡继续决定着参与者日常的服药(实施阶段)和对药物的坚持(或停止)。健忘和耻辱感被认为是影响实施阶段的负面因素,而药物成本和依赖性则影响停药阶段的依从性。
成年人开始、继续或停止用药的决定受到一系列因素的影响;有些因素在每个阶段都是独特的,而有些因素则贯穿于所有阶段。参与者在决定每个阶段是否坚持用药时,平衡了对药物的需求和对药物的担忧。当探讨依从性的三个阶段的药物决策时,NCF 似乎具有适用性。